Trace amines depress D2-autoreceptor-mediated responses on midbrain dopaminergic cells

British Journal of Pharmacology

Volumn 160, Issue 6, 2010, Pages 1509-1520

  Ledonne, Ada ^a,c   Federici, Mauro ^c   Giustizieri, Michela ^c   Pessia, Mauro ^d   Imbrici, Paola ^d   Millan, Mark J ^e   Bernardi, Giorgio ^b,c   Mercuri, Nicola B ^b,c  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

dopaminergic neurone; trace amine associated receptor 1; tyramine; phenylethylamine; receptors

Indexed keywords

1 PHENYL 3 IODOTYRAMINE; AUTORECEPTOR; DOPAMINE 2 RECEPTOR; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE; PHENETHYLAMINE; POTASSIUM CHANNEL; QUINPIROLE; TYRAMINE; UNCLASSIFIED DRUG; DOPAMINE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; G PROTEIN COUPLED RECEPTOR; PHENETHYLAMINE DERIVATIVE; TRACE AMINE-ASSOCIATED RECEPTOR 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; DOPAMINERGIC NERVE CELL; MESENCEPHALON; MOUSE; NONHUMAN; OOCYTE; POTASSIUM CURRENT; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TRANSGENIC MOUSE; XENOPUS; ANIMAL; C57BL MOUSE; DRUG EFFECTS; ELECTROPHYSIOLOGY; FEMALE; GENETICS; KNOCKOUT MOUSE; METABOLISM; XENOPUS LAEVIS;

ANIMALS; AUTORECEPTORS; DOPAMINE; ELECTROPHYSIOLOGY; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OOCYTES; PHENETHYLAMINES; QUINPIROLE; RECEPTORS, DOPAMINE D2; RECEPTORS, G-PROTEIN-COUPLED; SUBSTANTIA NIGRA; TYRAMINE; XENOPUS LAEVIS;

EID: 77954064771     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00792.x     Document Type: Article

References (67)

1. Alexander SPH, Mathie A, Peter JA (2009). Guide to receptors and channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1 S1 S254.
2. Bailey BA, Philips SR, Boulton AA (1987). In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine. Neurochem Res 12 : 173 178.
3. Barroso N, Rodriguez M (1996). Action of β-phenylethylamine and related amines on nigrostriatal dopamine neurotransmission. Eur J Pharmacol 297 : 195 203.
4. Bergman J, Yasar S, Winger G (2001). Psychomotor stimulant effects of beta-phenylethylamine in monkeys treated with MAO-B inhibitors. Psychopharmacology (Berl) 159 : 21 30.
5. Berry MD (2004). Mammalian central nervous system trace amines. Pharmacological amphetamines, physiological neuromodulators. J Neurochem 90 : 257 271.
6. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL et al. (2001). Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98 : 8966 8971.
7. Boulton AA (1976). Identification, distribution, metabolism, and function of meta and para tyramine, phenylethylamine and tryptamine in brain. Adv Biochem Psychopharmacol 15 : 57 67.
8. Boulton AA (1980). Trace amines and mental disorders. Can J Neurol Sci 7 : 261 263.
9. Bradaia A, Trube G, Stalder H, Norcross RD, Ozmen L, Wettstein JG et al. (2009). The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc Natl Acad Sci USA 106 : 20081 20086.
10. Branchek TA, Blackburn TP (2003). Trace amines receptors as target for novel therapeutics: legend, myth and fact. Curr Opin Pharmacol 3 : 90 97.
11. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI et al. (2001). Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60 : 1181 1188.
12. Burchett SA, Hicks TP (2006). The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. Prog Neurobiol 79 : 223 246.
13. + channels in a receptor-specific manner. Proc Natl Acad Sci USA 102 : 4643 4648.
14. Davis BA, Boulton AA (1994). The trace amines and their acidic metabolites in depression - an overview. Prog Neuropsychopharmacol Biol Psychiatry 18 : 17 45.
15. De Groote L, Gobert A, Brocco M, Rivet JM, Di Cara B, Veiga S et al. (2007). Genetic deletion of Trace Amine Associated Receptor 1 receptors does not compromise the actions of mechanistically diverse antidepressants: a neurochemical and behavioural analysis. Am Soc Neuroscience Abstracts 807 : 4.
16. Durden DA, Philips SR (1980). Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain. J Neurochem 34 : 1725 1732.
17. Dyck LE (1983). Release of monoamine from striatal slices by phenelzine and β-phenylethylamine. Prog Neuropsychopharmacol Biol Psychiatry 7 : 797 800.
18. B response in dopaminergic neurons by inhibiting G-βγ-gated inwardly rectifying potassium channels. Mol Pharmacol 67 : 1283 1290.
19. Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE (2009). The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous Sigma-1 receptor regulator. Science 323 : 934 937.
20. Ford CP, Phillips PE, Williams JT (2009). The time course of dopamine transmission in the ventral tegmental area. J Neurosci 29 : 13344 13352.
21. Geracitano R, Federici M, Prisco S, Bernardi G, Mercuri NB (2004). Inhibitory effects of trace amines on rat midbrain dopaminergic neurons. Neuropharmacology 46 : 807 814.
22. Grandy DK (2007). Trace amine-associated receptor-1 - family archetype or iconoclast? Pharmacol Ther 116 : 355 390.
23. Greenshaw A, Juorio AV, Nguyen TV (1986). Depletion of striatal β-phenylethylamine following dopamine but not 5-HT denervation. Brain Res Bull 17 : 477 484.
24. Guatteo E, Mercuri NB, Bernardi G, Knopfel T (1999). Group I metabotropic glutamate receptors mediate an inward current in rat substantia nigra dopaminergic neurons that is independent from calcium mobilization. J Neurophysiol 82 : 1974 1981.
25. Hart ME, Suchland KL, Miyakawa M, Bunzow JR, Grandy DK, Scanlan TS (2006). Trace amine-associated receptor agonists: synthesis and evalutation of thyronamines and related analogues. J Med Chem 49 : 1101 1112.
26. Itzhak Y, Stein I, Zhang SH, Kassim CO, Cristante D (1991). Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes. J Pharmacol Exp Ther 257 : 141 148.
27. Kabbani N, Levenson R (2007). A proteomic approach to receptor signaling: molecular mechanisms and therapeutic implications derived from discovery of the dopamine D2 receptor signalplex. Eur J Pharmacol 572 : 83 93.
28. + currents in neocortical neurons of the rat: a possible mechanism of β-phenylethylamine-induced seizures. Tohoku J Exp Med 215 : 333 340.
29. + channels by ifenprodil. Neuropsychopharmacology 31 : 516 524. (Pubitemid 43276967)
30. Kosa E, Marcilhac-Flouriot A, Fache MP, Siaud P (2000). Effects of beta-phenylethylamine on the hypothalamo-pituitary-adrenal axis in the male rat. Pharmacol Biochem Behav 67 : 527 535.
31. Lacey MG, Mercuri NB, North RA (1987). Dopamine acts on D2 receptors to increase potassium conductance in neurones of rat substantia nigra zona compacta. J Physiol 392 : 397 416.
32. B and dopamine D2 receptors in the rat substantia nigra neurons. J Physiol 401 : 437 453.
33. Lacey MG, Mercuri NB, North RA (1989). Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the action of dopamine and opioids. J Neurosci 9 : 1233 1241.
34. Lindemann L, Meyer CA, Jeanneau K, Bradaia A, Ozmen L, Bluethmann H et al. (2008). Trace amine-associated receptor 1 modulates dopaminergic activity. JPET 324 : 948 956.
35. + channels in rat neurohypophysial terminals requires neither G-protein nor ATP. J Physiol 526 : 527 539.
36. Maguire JJ, Parker WA, Foord SM, Bonner TA, Neubig RR, Davenport AP (2009). International Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclature. Pharmacol Rev 61 : 1 8.
37. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976). The effects of morphine and nalorphine like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197 : 517 532.
38. Mercuri NB, Bonci A, Calabresi P, Stefani A, Bernardi G (1995). Properties of the hyperpolarization-activated cation current Ih in rat midbrain dopaminergic neurons. Eur J Neurosci 7 : 462 469.
39. Millan MJ (2006). Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther 110 : 135 370.
40. Millan MJ, Rivet JM, Brocco M, Zhang X, Svenningsson P, Verdouw PM et al. (2008). Behavioural and neurochemical actions of thyronamines are blunted in Trace-Amine-Associated receptor 1 (TAAR1) receptor knock-out mice. Behav Pharmacol 20 (S1 S112.
41. Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H et al. (2005). Primate trace amine receptor 1 modulation by the dopamine transporter. J Pharmacol Exp Ther 313 : 983 994.
42. + channels in the heart. J Pharmacol Exp Ther 322 : 341 350.
43. Monnet FP, Maurice T (2006). The sigma-1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular and behavioural aspects. J Pharmacol Sci 100 : 93 118.
44. Nakamura M, Ishii A, Nakahara D (1998). Characterization of β-phenylethylamine induced monoamine release in rat nucleus accumbens: a microdioalysis study. Eur J Pharmacol 349 : 163 169.
45. + currents in rat locus coeruleus neurons in vitro. Eur J Pharmacol 361 : 157 163.
46. Paterson IA (1993). The potentiation of cortical neuron responses to noradrenaline by 2-phenylethylamine is independent of endogenous noradrenaline. Neurochem Res 18 : 1329 1336.
47. Paterson IA, Juorio AV, Boulton AA (1990). 2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system? J Neurochem 55 : 1827 1837.
48. Perry TL (1962). Urinary excretion of amines in phenylketonuria and mongolism. Science 136 : 879 880. Pharmacol Ther 116: 355-390.
49. + channels. EMBO J 15 : 2980 2987.
50. Philips SR, Robson AM (1983). In vivo release of endogenous dopamine from the rat caudate nucleus by phenylethylamine. Neuropharmacology 22 : 1297 1301.
51. Pirri JK, McPherson AD, Donnelly JM, Francis MM, Alkema MJ (2009). A tyramine-gated chloride channel coordinates distinct motor programs of a Caenorhabditis elegans escape response. Neuron 62 : 526 538.
52. Premont RT, Gainetdinov RR, Caron MG (2001). Following the trace of elusive amines. Proc Natl Acad Sci USA 98 : 9474 9475.
53. Raiteri M, Del Carmen R, Bertollini A, Levi G (1977). Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol 41 : 133 143.
54. Richard L, Hauger T, Philskolnick, Steven MP (1982). Specific [3H]IS-Phenylethylamine binding sited in rat brain. Eur J Pharmacol 83 : 147 148.
55. Ringstad N, Abe N, Horvitz R (2009). Ligand gated chloride channels are receptors for biogenic amines in C. elegans. Science 325 : 96 100.
56. Satoi M, Matsuishi T, Yamada S, Yamashita Y, Ohtaki E, Mori K et al. (2000). Decreased cerebrospinal fluid levels of beta-phenylethylamine in patients with Rett syndrome. Ann Neurol 47 : 801 803.
57. Sotnikova TD, Zorina OI, Ghisi V, Caron MG, Gainetdinov RR (2008). Trace amine associated receptor 1 and movement control. Parkinsonism Relat Disord 14 : 99 102.
58. Stoof JC, Liem AL, Mulder AH (1976). Release and receptor stimulating properties of p-tyramine in rat brain. Arch Int Pharmacodyn 220 : 62 71.
59. Suppes T, Pinnock RD (1987). Sensitivity of neuronal dopamine response in the substantia nigra and ventral tegmentum to clozapine, metoclopramide and SCH 23390. Neuropharmacology 26 : 331 337.
60. Vaccari A (1986). High affinity binding of [3h]-tyramine in the central nervous system. Br J Pharmacol 89 : 15 25.
61. Werner P, Hussy N, Buell G, Jones KA, North RA (1996). D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium chennels in Xenopus oocytes. Mol Pharmacol 49 : 656 661.
62. Xie Z, Miller GM (2009). Trace amine-associated receptor 1 as a monoaminergic modulator in brain. Biochem Pharmacol 78 : 1095 1104.
63. Xie Z, Westmoreland SV, Bahn ME, Chen G, Yang H, Vallender E et al. (2007). Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by D2 autoreceptor in vitro. J Pharmacol Exp Ther 321 : 116 127.
64. Xie Z, Westmoreland SV, Miller GM (2008). Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes. J Pharmacol Exp Ther 325 : 629 640.
65. Zhang H, Cuevas J (2002). Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. J Neurophysiol 87 : 2867 2879.
66. Zhang H, Cuevas J (2005). σ receptor activation blocks potassium channels and depresses neuroexcitability in rat intracardiac neurons. J Pharmacol Exp Ther 313 : 1387 1396.
67. Zhu ZT, Munhall AC, Johnson SW (2007). Tyramine excites rat subthalamic neurons in vitro by a dopamine-dependent mechanism. Neuropharmacology 52 : 1169 1178.